LILA visionary.art
Pharmakon Complexes Fly Agaric–Circumboreal Complex
CEREMONIAL / ETHNOMYCOLOGICAL COMPLEX · CIRCUMBOREAL EURASIA

Fly Agaric–Circumboreal Complex

Amanita muscaria sensu lato · mukhomor · wapaq · Siberian divination · mushroom-persons · reindeer · hypothesis field
Prehistory no securely identified sacramental deposit→ · Written reports seventeenth–eighteenth centuries→ · Ethnography Bogoras & Jochelson · 1900s→ · Digital market 2020s

Fly agaric is best understood as a mobile circumboreal assemblage whose strongest ethnographic centre lies in Siberia and the Russian Far East. There Amanita muscaria could serve, in different communities and periods, as divinatory agent, medicine, stimulant, social intoxicant and shamanic vehicle; its effects circulated through dried fruitbodies, trade, observation of reindeer and the documented reuse of human urine. Around that record has accumulated another history of hypotheses—Vedic Soma, Sámi magic, Norse berserkers, Christmas and medieval Christian imagery—whose evidence ranges from serious comparison to modern folklore. The mushroom’s contemporary life is different again: a global fairy-tale pictogram, a forest symbiont turned southern-hemisphere invader, a source of GABAergic research compounds and a poorly standardised commercial intoxicant. This dossier keeps those layers in relation without assigning them equal evidential weight (Jochelson, 1908; Saar, 1991a; Michelot and Melendez-Howell, 2003; Winkelman, 2022).

1 plant indexed Amanita muscaria

Constituents & preparation

One conspicuous fungus inside a northern ecology

The operative “complex” is not a botanical admixture. It joins a mycorrhizal fungus to trees, seasonal travel, animal observation, trade, specialist knowledge and social circulation.

Amanita muscaria (L.) Lam. sensu lato

Fly agaric · fly amanita · mukhomor · regional names including Koryak wapaq

A large ectomycorrhizal agaric native across boreal and temperate regions of the Northern Hemisphere and carried with forestry into parts of the Southern Hemisphere. The familiar red cap with pale veil remnants is only one phenotype: orange, yellow and pale forms occur, and molecular work has resolved strong intercontinental structure and cryptic lineages. “A. muscaria” on a global ethnomycological page is therefore a practical species-complex label, not an assertion that every population is genetically identical (Geml et al., 2006; Geml et al., 2008).

Accepted nameAmanita muscaria (L.) Lam.; global circumscription under active revisionFamily / orderAmanitaceae · Agaricales · BasidiomycotaMorphologyVeil-covered “egg”; usually red–orange pileus with pale warts; white free gills and spore print; skirt-like annulus; bulbous base with volval ringsEcologyEctomycorrhizal with birch, pine, spruce, fir and other trees; fruits seasonally from soilPrincipal activesIbotenic acid and muscimol; muscazone minor; muscarine usually only trace

Circumboreal assemblage

Forest edge · tundra trade · reindeer · vessels · household and specialist use

Fruitbodies do not occur evenly across tundra and forest. Historical accounts describe exchange from mushroom-rich districts into regions where they were scarce, giving dried specimens commodity value. Reindeer independently seek the fungus and can become visibly intoxicated. Humans’ reuse of the urine of an intoxicated person is well documented; the now-popular image of a shaman routinely drinking reindeer urine has a much thinner primary record and should not be substituted for it (Jochelson, 1908; Saar, 1991a; Lee, Dukan and Milne, 2018).

Eastern centreKamchatka, Chukotka and adjoining north-eastern SiberiaWestern / northernKhanty, Mansi and selected Nenets and Yukaghir records; isolated reports elsewhereAnimal relationReindeer consumption and intoxication are observed facts; human ritual meanings varySocial circulationGift, trade, household hospitality, specialist use and documented human-urine recycling
Associated fungi, organisms and media

Amanita pantherina

Panther cap

Contains the same principal isoxazoles and can produce a similar, often severe “pantherine” syndrome. It belongs in toxicological comparison, not automatically in the Siberian ritual archive (Vendramin and Brvar, 2014).

Birch and conifer hosts

Betula · Pinus · Picea · Abies

The visible mushroom is a seasonal fruitbody of an underground fungal partnership. Host-tree distributions shape availability, trade and modern biological invasion.

Reindeer

Rangifer tarandus

Reindeer seek fly agaric and show altered behaviour after eating it. Ethnographic observation of this relation is secure; modern Christmas genealogies built from it are not.

Human urine

Re-ingestion · sharing · status and scarcity

Muscimol is excreted substantially unmetabolised. Historical reports describe urine being collected or sought after ingestion, sometimes allowing several passages of intoxication (Michelot and Melendez-Howell, 2003).

Drum, song and movement

Trance without a single necessary drug

Siberian shamans also worked through drumming, dancing, costume, vocal performance and spirit relations. Fly agaric was one technique among others, not the universal cause of “shamanism”.

Fly-killing preparations

Milk or liquid lure · European vernacular history

The English name and Latin epithet relate to the fungus’s use against flies. This domestic history helped make the species familiar outside intoxication contexts (Carboué and Lopez, 2021).

Safety and scope: this page records drying, liquid preparation and urine reuse because they are ethnographically significant, but gives no quantities, temperatures or processing recipe. Wild specimens vary sharply in isoxazole content; severe delirium, seizures, coma and rare fatalities are documented. Internet “detoxification” claims cannot turn variable wild material into a predictably safe product (FDA, 2024; Stoeva-Grigorova et al., 2025).

Associated compounds

CompoundPharmacologyExperiential / toxicological relevanceCorrection
MuscimolPotent orthosteric agonist at GABAA receptors; crosses the blood–brain barrier and is eliminated largely unchanged in urine.CNS depression, dreamlike imagery, altered scale and space, ataxia, myoclonus, agitation alternating with sleep and, at high exposure, seizures or coma.It is pharmacologically unlike serotonergic psychedelics such as psilocin, DMT or mescaline.
Ibotenic acidIsoxazole amino acid and glutamate-receptor agonist, especially at NMDA sites; partly decarboxylates to muscimol.Contributes excitatory and toxic effects. Concentrations vary among specimens, tissues, seasons and processing states.A dried cap, extract or gummy cannot be assigned a safe potency from appearance or label alone.
MuscazoneMinor isoxazole derivative formed in or from fungal chemistry.Less well characterised than ibotenic acid and muscimol and not established as the principal intoxicant.Minor presence should not be inflated into a clinically defined “entourage” mechanism.
MuscarinePeripheral muscarinic acetylcholine-receptor agonist.Historically isolated from and named after A. muscaria, but normally occurs only in trace quantities in this species.Despite the name, muscarine is not the main explanation for fly-agaric vision or delirium (Michelot and Melendez-Howell, 2003; Ordak, 2026).

Traditional preparation: evidence without a recipe

FRUITBODY

Historical sources describe mushrooms dried in sun or near heat, stored, chewed or swallowed, and sometimes steeped in liquid. Preparation varied by people, household and occasion. Drying alters the ibotenic-acid/muscimol balance but does not create a standardised medicine (Saar, 1991a; Feeney, 2010).

HUMAN URINE

North-eastern accounts record drinking the urine of someone who had consumed the fungus. Pharmacokinetically this is plausible because active muscimol passes into urine; socially it could redistribute a scarce commodity and distinguish those purchasing fruitbodies from those receiving a later passage (Jochelson, 1908; Michelot and Melendez-Howell, 2003).

FERMENTED / MIXED LIQUIDS

Several travel and ethnographic records mention liquids, including mixtures with berry juice or later alcohol. The archive is uneven and often colonial; one reported form should not be turned into a pan-Siberian recipe.

REINDEER URINE AS HUMAN SACRAMENT

Reindeer eating the fungus is well observed, but the viral claim that Sámi or Siberian shamans characteristically fed reindeer and drank their urine lacks a comparably secure chain of primary documentation. Human urine recycling is the stronger historical claim.

Culture

Peoples and territories

Kamchatka and adjacent Okhotsk territories
Koryak · Itelmen / historical “Kamchadal” records

The Koryak archive is central because Jochelson recorded household, ritual and mythic dimensions together: scarcity and exchange, intoxication, spirit-persons and the Big Raven narrative. Itelmen districts could also supply mushrooms into trade (Jochelson, 1908; Saar, 1991a).

Chukotka
Chukchi · coastal and reindeer-herding lifeways

Bogoras documented fly-agaric intoxication among Chukchi interlocutors within a wider account of spirit relations, shamanic practice and social life. Use was neither confined to one formal priesthood nor equivalent in every settlement (Bogoras, 1904–1909).

Western Siberian forest and river worlds
Khanty and Mansi; selected Nenets reports

Sources describe more specialist and divinatory uses among Uralic-speaking peoples, including diagnosis, foreknowledge and performance. The contrast with north-eastern household use is useful but schematic, because the record spans different dates and observers (Saar, 1991a; Saar, 1991b).

North-eastern and central Siberian margins
Yukaghir · Even / Evenki and other isolated reports

The evidence thins outside the best-documented centres. A mention of use by an individual or neighbouring group is not proof of a uniform ethnic tradition. Trade and cultural contact are often more plausible than bounded “tribal drug cults”.

Three internal formations

Koryak–Chukchi–Itelmen uses

Divination · social intoxication · work · story · healing
  • Shamans and non-specialists both appear in the archive; contexts include ceremonial work, hospitality, entertainment, divination and practical labour.
  • Mushroom-persons could be experienced as directing the intoxicated person’s actions, showing routes, answering questions or imposing repetitive conduct.
  • Dried mushrooms moved by exchange into districts with limited forest habitat, giving access an economic and seasonal structure.
  • Colonial observers sometimes translated unfamiliar practice as drunkenness or superstition; the same reports nevertheless preserve indispensable details.

Khanty–Mansi and related records

Specialist trance · diagnosis · epic and spirit communication
  • Western Siberian reports more often restrict or associate use with ritual specialists, although drumming and dream were equally important trance technologies.
  • Recorded aims include learning the cause of illness, finding missing persons or animals, predicting events and obtaining spirit instruction.
  • Khanty medicine also used fungi in non-intoxicating forms; fly agaric must be placed within a larger pharmacopoeia rather than treated as its entirety.
  • Ethnonyms such as “Ostyak” and “Vogul” in older sources are historical exonyms, not preferred contemporary names.

Trade, urine and reindeer

Scarcity · metabolic passage · animal appetite · northern mobility
  • Forest ecology determines where mushrooms fruit; tundra scarcity could turn them into high-value objects of exchange.
  • Urine reuse makes intoxication a social circulation: the body becomes a metabolic passage through which active substance remains available.
  • Reindeer’s attraction to the fungus offered an observable non-human model of altered behaviour and linked mycology to pastoral and hunting knowledge.
  • Modern retellings often collapse these three relations into a single Christmas tableau; the archive keeps them distinct.

History and evidence

Ritual practice

01

Acquire and preserve

Seasonal fruitbodies were gathered or received by exchange, then dried and stored. Geography and household wealth affected access.

02

Frame the question

Use might be directed toward illness, lost animals, travel, future events, spirit contact, work or collective amusement—not one universal liturgy.

03

Receive the mushroom-persons

Accounts describe agents appearing in forms related to the mushrooms and compelling speech, movement, repetition or journeys.

04

Perform and interpret

Singing, dancing, mimicry, somnolence and sudden exertion become socially observed events whose significance depends on the occasion.

05

Circulate

In documented north-eastern contexts, urine could transmit active muscimol to another person and extend a scarce intoxicant’s social life.

06

Return and verify

A divination was evaluated by whether animals were found, an illness changed, a route proved true or a narrative became collectively persuasive.

Mythology and cosmology

Big Raven and the whale. In Jochelson’s Koryak record, Big Raven cannot return a stranded whale to the sea. Vahiyinin (“Existence”) causes the wapaq to appear; after eating them, Raven gains strength and the mushrooms show him how the whale will return. The story makes fly agaric simultaneously a spirit-being, helper and source of disclosed action (Jochelson, 1908).

Mushroom-persons. Koryak and Chukchi descriptions do not merely say that inert mushrooms produce pictures. The wapaq or fly-agaric beings can speak, command, lead and multiply according to the mushrooms taken. “Hallucination” names a perceptual event but does not exhaust this indigenous theory of agency.

Vertical travel and altered strength. Some accounts connect intoxication with ascent, descent, animal transformation, unusual endurance or the loosening of ordinary bodily scale. These motifs belong to wider Siberian shamanic cosmologies as well as to the mushroom’s pharmacology; neither alone explains their local form.

Reindeer knowledge. Reindeer are not picturesque accessories. Their appetite for the fungus places human intoxication inside observed animal behaviour, hunting and pastoral worlds. Different communities could treat that fact practically, comically or cosmologically.

Shamanism and healing

“Shamanism” is a comparative category built partly from Tungusic language and the history of Russian ethnography. In the fly-agaric archive it covers distinct offices: diagnosing a patient, recovering a lost soul, negotiating with spirit agents, foretelling a hunt, leading song or demonstrating power. In western Siberia mushroom use is more often described as specialist; in north-eastern sources non-specialists also consume it. The fungus therefore does not define who is a shaman, nor was it necessary to every shamanic performance (Bogoras, 1904–1909; Jochelson, 1908; Saar, 1991a).

Healing could involve ingesting fly agaric for diagnostic knowledge, applying it in folk remedies, or treating the intoxicant itself as a dangerous power requiring expertise. Modern biomedical claims for anxiety, sleep, pain or addiction should not be projected backward as the hidden meaning of traditional use. Conversely, historical medicinal use does not establish efficacy for retail extracts (Hartwig et al., 2025; Ordak, 2026).

Art and material culture

Hypothesis register

ProposalArgumentEvidence assessment
Vedic SomaWasson compared Soma’s brilliance, mountain origin, lack of roots/leaves and filtered or urinary imagery with fly agaric and Siberian reuse.Influential, unresolved A serious comparative hypothesis, challenged philologically and botanically; the Rigveda does not securely name A. muscaria (Wasson, 1968; Brough, 1971; Feeney, 2010).
Sámi sacramentScattered reports and later comparisons link Sámi noaidi practice, reindeer and fly agaric.Limited reports Evidence does not support a uniform Sámi mushroom cult, and reindeer-urine claims are especially weak. It should be presented as local or disputed testimony, not ethnic fact.
Norse berserkersSince Samuel Ödmann (1784), fly agaric has been proposed as the cause of berserkergang.Abductive No Norse text or residue identifies it; symptom matching is poor and henbane has been argued as a better, still speculative candidate (Fatur, 2019).
Christmas / SantaRed-and-white costume, reindeer, gifts, winter trees and smoke-hole entry are assembled into a Siberian mushroom genealogy.Popular synthesis Resemblances exist, but no historical chain derives Santa Claus from fly-agaric shamanism. The theory is modern folklore about folklore.
Christian and Edenic mushroom imageryAmbiguous plants in medieval art are identified as fly agaric and used to posit suppressed entheogenic Christianity.Iconographic conjecture Identification often precedes evidence; textual, material and provenance support is generally absent. Individual images require case-by-case art history.

Visionary phenomenology

Fly-agaric phenomenology is frequently called “psychedelic”, but its neuropharmacology and experiential structure differ from classical 5-HT2A psychedelics. The recurrent field is one of unstable alternation: excitation and heaviness, compulsive movement and deep sleep, lucid-seeming dream and delirious misrecognition. Historical reports are further shaped by translation and by observers who often treated all intoxication as drunkenness. The most responsible description therefore triangulates ethnography, clinical toxicology and contemporary self-report without flattening any one into the others (Michelot and Melendez-Howell, 2003; Hartwig et al., 2025).

Temporal and experiential profile

Onset · often 30 minutes to 3 hours

Nausea, salivation or sweating may occur with dizziness, bodily heaviness, tingling, changes in sound and light, restlessness or sudden drowsiness. Latency varies with material and circumstance.

Intensification · irregular rather than linear

Ataxia, tremor or myoclonus can accompany euphoria, fear, repetitive gestures, pressured speech and abrupt shifts of attention. The person may look profoundly intoxicated before reporting coherent imagery.

Vision / dream · scaled and inhabited space

Macropsia and micropsia, altered distance, weightlessness, vivid coloured scenes, personified presences, looping actions and immersive dreams are recurrent. Eyes-open and eyes-closed states may interpenetrate.

Somnolence and return · several hours

Deep sleep can interrupt or conclude the acute state. Confusion, fatigue, headache or fragmentary memory may persist into the next day; rare prolonged neuropsychiatric effects are reported.

Intensity and interpretive setting

VARIABLE INTENSITY

Specimen chemistry and individual response are highly variable. Reports range from mild sedation or stimulation to incapacitating delirium, seizures and coma; “microdose” branding does not guarantee a small or even authentic dose (Correia et al., 2025; Stoeva-Grigorova et al., 2025).

CULTURAL SALIENCE

A Koryak account of mushroom-persons and a contemporary consumer’s report of dreamlike sedation may share perceptual features without sharing an ontology. The former is interpreted through named beings, stories and practical verification.

“ALICE IN WONDERLAND”

Altered scale makes the literary association tempting, but Lewis Carroll never identifies the mushroom as fly agaric and no secure evidence demonstrates pharmacological inspiration. It is a productive later reading, not established authorial history.

> Let the Agaric remain on earth, and let my children see what it will show them. — Big Raven in a Koryak narrative recorded by Jochelson (1908, p. 583). The wording comes through English ethnographic translation.

Contemporary transformations

From ethnographic specimen to digital “legal psychedelic”

Contemporary formationWhat changedScholarly implication
Online ethnomycologyForums and video platforms circulate identification, self-treatment narratives and preparation claims faster than clinical evidence.Digital testimony is genuine social data but remains self-selected, unverifiable and unsuitable as efficacy evidence (Hartwig et al., 2025).
Retail edible marketCaps, extracts, gummies, chocolate and vapes are sold as “mushroom” or “legal psychedelic” products, often beside hemp-derived cannabinoids.The category encourages confusion with psilocybin and masks radical variation in ingredients, formulation and regulation (Leas et al., 2024).
Neo-entheogenic identitySome users build practice around dreams, sobriety, anxiety, sleep or a personified “mushroom teacher”, drawing selectively on Siberian narratives.This is an emergent modern tradition with its own anthropology; historical borrowing should be documented rather than passed off as unbroken lineage.
Commodity iconThe red-and-white cap functions as décor, fantasy token, fashion motif and algorithm-friendly product identity.Visual fame can make a toxic fungus seem familiar and therefore safe, even as many consumers cannot distinguish its pharmacology from psilocybin.

Public health and product integrity

FDA food determination · 2024
United States food regulation

After reviewing more than 600 publications, the FDA concluded that A. muscaria, its extracts, muscimol, ibotenic acid and muscarine are not generally recognised as safe and are unapproved food additives in conventional food (FDA, 2024).

Diamond Shruumz outbreak · 2024 evidence analysed in 2026
180 severe cases · 34 states

CDC’s national analysis recorded 73 hospitalisations, 38 intensive-care admissions, 29 intubations and two deaths. Testing found different mixtures across products, including muscimol, psilocin, acetylpsilocin, kavalactones and pregabalin; it was a mixed-product outbreak, not proof of a single Amanita mechanism (Rumph et al., 2026).

Analytical mismatch · 2025
Products marketed as Amanita

Targeted analysis found some recreational products suggesting fly-agaric content instead contained serotonergic tryptamines. A package can invoke muscimol culture while delivering a pharmacologically different drug (Correia et al., 2025).

Clinical evidence gap
Self-treatment claims ≠ trials

There are no robust controlled human trials establishing fly-agaric preparations as treatments for depression, anxiety, pain, sleep disorder or addiction. The human literature remains dominated by poisoning reports, retrospective accounts and online discourse (Ordak, 2026).

Conservation, ecology and biological movement

Amanita muscaria sensu lato has no single global IUCN assessment and is common in many native landscapes. Conservation concern is therefore unlike that surrounding peyote or iboga. The more urgent scientific questions are taxonomic: which cryptic lineages are being grouped under the red-cap name, what fungal diversity is lost when records are collapsed, and how introduced lineages behave with new host trees (Geml et al., 2006; Geml et al., 2008).

Forestry moved European fly-agaric lineages with pines and other seedlings to South Africa, Australasia and South America. In some southern landscapes the fungus has shifted from exotic plantation hosts toward native vegetation. Genome and metabolome research published in 2026 reconstructed South African introductions and found specialised-metabolite capacities conserved in the novel range, illustrating how an ethnobotanical icon is also an invasive symbiont (Nickles et al., 2026).

Law: mushroom, molecule and food are different objects

Jurisdiction / layerPosition at review dateCaution
United States · federalA. muscaria, muscimol and ibotenic acid are not scheduled under the federal Controlled Substances Act. The FDA nevertheless treats their addition to conventional food as use of an unsafe, unapproved food additive (FDA, 2024).“Unscheduled” does not mean approved as food, medicine or supplement.
LouisianaState law specifically restricts production, manufacture, distribution and possession of A. muscaria and preparations intended for human consumption, with limited exemptions including ornamental use.State rules can be stricter than federal scheduling.
United KingdomThe species and its isoxazoles are not named as controlled drugs under the Misuse of Drugs Act schedules, but commercial supply for psychoactive consumption may engage the Psychoactive Substances Act 2016 and food-safety law.Picking, possession, supply and sale as food are legally distinct; obtain current local advice.
InternationalNo unitary global regime exists. Some states control muscimol or psychoactive Amanita species; others regulate only products, claims or food use.Online claims that it is “legal everywhere” are unreliable.

Patents, neuroscience and current research

Standardising an unstable commodity

Extraction · conversion ratios · scaled manufacture
  • US8784835B2 claims methods for producing muscimol and/or reducing ibotenic acid from Amanita tissue.
  • WO2022187974A1 and WO2024173903A1 claim extraction and scale-up processes designed to increase muscimol relative to ibotenic acid.
  • A patent is a legal claim to an invention, not proof of safety, efficacy or cultural legitimacy.

A classic laboratory tool, not a clinical psychedelic platform

GABAA activation · reversible inactivation · lesion models
  • Muscimol is widely microinjected in animal neuroscience to suppress local circuit activity reversibly.
  • Ibotenic acid is widely used to create excitotoxic lesions in experimental animals.
  • These uses reveal receptor and circuit action but do not constitute therapeutic evidence for consuming the fungus.

Products, users and genomes

Digital ethnography · analytical toxicology · invasion genomics
  • Hartwig et al. analysed 998 Reddit posts and 9,542 comments to map motives, perceived benefits and adverse experience.
  • Stoeva-Grigorova et al. synthesised acute toxicity and clinical cases; CDC quantified a large mixed-product outbreak.
  • Nickles et al. used 24 genomes plus metabolomics to reconstruct the introduced South African complex.

Linked species

Primary species page

Amanita muscaria

Taxonomy, morphology, biogeography, chemistry and poisoning profile separated from the wider ceremonial complex.

Toxicological analogue

Amanita pantherina

Related isoxazole-containing species producing pantherine syndrome; not automatically a ritual substitute.

Comparative fungal complex

Psilocybin mushroom traditions

Serotonergic fungi with distinct chemistry, history and Mesoamerican divinatory institutions.

Hypothesis cross-link

Soma–Haoma Complex

Where the Amanita identification belongs within the wider philological, botanical and ritual candidate field.

Cross-index

Soma–HaomaWasson’s hypothesis uses Siberian fly-agaric practice to interpret Vedic Soma; correspondence is suggestive but not identification. CONTESTED CANDIDATE
Mazatec medicinesBoth organise visionary fungi through divination and specialist interpretation, but differ in fungal chemistry, colonial history, language and ritual form. DIVINATORY FUNGUS
Neo-psychedelicsOnline self-treatment, retail extracts and unscheduled-market positioning make contemporary Amanita a natural organism circulating like a novel psychoactive substance. EMERGENT TECHNOCULTURE
Norse entheogen hypothesesBerserker attribution belongs to an abductive hypothesis field and currently lacks direct textual or archaeological evidence. EVIDENCE REGISTER

Bibliography

Harvard style (Cite Them Right) · DOI and stable-record links · 34 sources

Botany & taxonomy

01 · 5 sources
Carboué, Q. and Lopez, M. (2021) ‘Amanita muscaria: ecology, chemistry, myths’, Encyclopedia, 1(3), pp. 905–914. Available at: https://doi.org/10.3390/encyclopedia1030069.
DOI checked
Open record ↗
Geml, J., Laursen, G.A., O’Neill, K., Nusbaum, H.C. and Taylor, D.L. (2006) ‘Beringian origins and cryptic speciation events in the fly agaric (Amanita muscaria)’, Molecular Ecology, 15(1), pp. 225–239. Available at: https://doi.org/10.1111/j.1365-294X.2005.02799.x.
Verified
Open record ↗
Geml, J., Tulloss, R.E., Laursen, G.A., Sazanova, N.A. and Taylor, D.L. (2008) ‘Evidence for strong inter- and intracontinental phylogeographic structure in Amanita muscaria, a wind-dispersed ectomycorrhizal basidiomycete’, Molecular Phylogenetics and Evolution, 48(2), pp. 694–701. Available at: https://doi.org/10.1016/j.ympev.2008.04.029.
Verified
Open record ↗
Index Fungorum (2026) ‘Amanita muscaria (L.) Lam., Record ID 161267’. Available at: indexfungorum.org (Accessed: 29 July 2026).
Verified
Open record ↗
Nickles, G.R., Stokes, C.K., Narh, D.L. et al. (2026) ‘Equipped for success: genomes and metabolomes of the European Amanita muscaria are conserved in its novel South African range’, New Phytologist, 250(3), pp. 1863–1883. Available at: https://doi.org/10.1111/nph.71064.
Verified
Open record ↗

Chemistry & pharmacology

02 · 1 sources
Michelot, D. and Melendez-Howell, L.M. (2003) ‘Amanita muscaria: chemistry, biology, toxicology, and ethnomycology’, Mycological Research, 107(2), pp. 131–146. Available at: https://doi.org/10.1017/S0953756203007305.
Verified
Open record ↗

Ethnography, ritual & cosmology

03 · 14 sources
Bogoras, W. (1904–1909) The Chukchee. Jesup North Pacific Expedition, vol. 7. Leiden and New York: E.J. Brill and American Museum of Natural History. Available at: Internet Archive.
Primary ethnography
Open record ↗
Brough, J. (1971) ‘Soma and Amanita muscaria’, Bulletin of the School of Oriental and African Studies, 34(2), pp. 331–362. Available at: https://doi.org/10.1017/S0041977X0012957X.
Verified
Open record ↗
Devlet, E.G. (2001) ‘Rock art and the material culture of Siberian and Central Asian shamanism’, in Price, N.S. (ed.) The Archaeology of Shamanism. London: Routledge, pp. 43–54.
book chapter
Dikov, N.N. (1971) Naskal’nye zagadki drevnei Chukotki: Petroglify Pegtymelia [Rock Art Riddles of Ancient Chukotka: The Petroglyphs of Pegtymel]. Moscow: Nauka.
archaeological monograph
Fatur, K. (2019) ‘Sagas of the Solanaceae: speculative ethnobotanical perspectives on the Norse berserkers’, Journal of Ethnopharmacology, 244, 112151. Available at: https://doi.org/10.1016/j.jep.2019.112151.
Verified
Open record ↗
Feeney, K. (2010) ‘Revisiting Wasson’s Soma: exploring the effects of preparation on the chemistry of Amanita muscaria’, Journal of Psychoactive Drugs, 42(4), pp. 499–506. Available at: https://doi.org/10.1080/02791072.2010.10400712.
Verified
Open record ↗
Jochelson, W. (1908) The Koryak. Jesup North Pacific Expedition, vol. 6. Leiden and New York: E.J. Brill and American Museum of Natural History. Available at: AMNH Digital Library.
primary ethnography
Open record ↗
Krasheninnikov, S.P. (1764) The History of Kamtschatka, and the Kurilski Islands, with the Countries Adjacent. Translated by J. Grieve. Gloucester: R. Raikes. Available at: Internet Archive.
historical source
Open record ↗
Saar, M. (1991a) ‘Ethnomycological data from Siberia and North-East Asia on the effect of Amanita muscaria’, Journal of Ethnopharmacology, 31(2), pp. 157–173. Available at: https://doi.org/10.1016/0378-8741(91)90002-U.
Verified
Open record ↗
Saar, M. (1991b) ‘Fungi in Khanty folk medicine’, Journal of Ethnopharmacology, 31(2), pp. 175–179. Available at: https://doi.org/10.1016/0378-8741(91)90003-V.
Verified
Open record ↗
Samorini, G. (2022) ‘“Lenin was a mushroom”: Russian post-Soviet history of fly-agaric’, Antrocom Online Journal of Anthropology, 18(1), pp. 5–27. Available at: Antrocom.
journal PDF
Open record ↗
Strahlenberg, P.J. von (1730) Das Nord- und Ostliche Theil von Europa und Asia. Stockholm. Available at: Internet Archive.
historical source
Open record ↗
Wasson, R.G. (1968) Soma: Divine Mushroom of Immortality. New York: Harcourt Brace Jovanovich.
Hypothesis
Open record ↗
Winkelman, M.J. (2022) ‘Amanita muscaria: Fly Agaric history, mythology and pharmacology’, Journal of Psychedelic Studies, 6(1), pp. 1–12. Available at: https://doi.org/10.1556/2054.2022.00216.
DOI checked
Open record ↗

Law, policy & patents

04 · 6 sources
Austin, T. (2014) ‘Method for producing muscimol and/or reducing ibotenic acid from Amanita tissue’, US Patent US8784835B2, granted 22 July. Available at: Google Patents (Accessed: 29 July 2026).
granted patent
Open record ↗
Leas, E.C., Satybaldiyeva, N., Kepner, W. et al. (2024) ‘Need for a public health response to the unregulated sales of Amanita muscaria mushrooms’, American Journal of Preventive Medicine, 67(3), pp. 458–463. Available at: https://doi.org/10.1016/j.amepre.2024.05.006.
Verified
Open record ↗
Louisiana State Legislature (2026) ‘RS 40:989.1—Unlawful production, manufacture, distribution, or possession of hallucinogenic plants; exceptions’. Available at: legis.la.gov (Accessed: 29 July 2026).
official law
Open record ↗
Psyched Wellness Corp. (2022) ‘Processes for extracting muscimol from Amanita muscaria’, International Patent Application WO2022187974A1, published 9 September. Available at: WIPO Patentscope (Accessed: 29 July 2026).
patent application
Open record ↗
Psyched Wellness Corp. (2024) ‘Amanita muscaria mushroom extracts and methods of producing the same’, International Patent Application WO2024173903A1, published 29 August. Available at: Google Patents (Accessed: 29 July 2026).
patent application
Open record ↗
U.S. Food and Drug Administration (FDA) (2024) Scientific Memorandum: Amanita muscaria (9 September 2024). Available at: fda.gov (Accessed: 29 July 2026).
official memorandum
Open record ↗

Toxicology & safety

05 · 3 sources
Ordak, M. (2026) ‘Amanita muscaria in the evolving novel psychoactive substances landscape—toxicological risks and clinical implications: a narrative review’, Frontiers in Pharmacology, 17, 1838212. Available at: https://doi.org/10.3389/fphar.2026.1838212.
Verified
Open record ↗
Rumph, J.T., Winquist, A., Troeschel, A.N. et al. (2026) ‘Severe illness associated with eating mushroom-containing chocolate products—United States, January–October 2024’, MMWR Morbidity and Mortality Weekly Report, 75(13), pp. 179–184. Available at: CDC.
Verified
Open record ↗
Stoeva-Grigorova, S. et al. (2025) ‘Acute Amanita muscaria toxicity: a literature review and case series’, Toxins, 17(12), 570. Available at: https://doi.org/10.3390/toxins17120570.
Verified
Open record ↗

Visionary phenomenology

06 · 5 sources
Correia, M.S., Gonzaga, M.J., Temple, C. and Gerona, R.R. (2025) ‘Quantitative analysis of recreational psychoactive mushroom gummies in Portland, Oregon’, Clinical Toxicology, pp. 1–6. Available at: https://doi.org/10.1080/15563650.2025.2450240.
DOI checked
Open record ↗
Hartwig, J., Kendrick, J., Ahmad, G. et al. (2025) ‘Exploring user experiences with Amanita muscaria: a thematic analysis of Reddit online forum discussions’, Substance Use & Misuse, 60(7), pp. 952–961. Available at: https://doi.org/10.1080/10826084.2025.2476141.
DOI checked
Open record ↗
Lee, M.R., Dukan, E. and Milne, I. (2018) ‘Amanita muscaria (fly agaric): from a shamanistic hallucinogen to the search for acetylcholine’, Journal of the Royal College of Physicians of Edinburgh, 48(1), pp. 85–91. Available at: https://doi.org/10.4997/JRCPE.2018.119.
DOI checked
Open record ↗
Maung, A.C., Hennessey, M. and Kadiyala, R. (2023) ‘Accidental colourful mushroom poisoning—delirium, delusions and dreams’, Clinical Medicine, 23(4), pp. 417–419. Available at: https://doi.org/10.7861/clinmed.2023-0103.
DOI checked
Open record ↗
Vendramin, A. and Brvar, M. (2014) ‘Amanita muscaria and Amanita pantherina poisoning: two syndromes’, Toxicon, 90, pp. 269–272. Available at: https://doi.org/10.1016/j.toxicon.2014.08.067.
DOI checked
Open record ↗